
Lifebit is a precision medicine software company specializing in enterprise data platforms for sensitive genomic and biomedical datasets. Their patented federated technology enables secure, in-situ analysis of distributed clinical and multi-omic data without moving it, preserving data privacy and compliance. Key products include the Lifebit Federated Platform, Trusted Data Lakehouse, Trusted Research Environment (TRE), and AI-driven tools like Target ID and NF-Copilot. Lifebit's platform supports large-scale biomedical data research across over 250 million patient datasets globally, spanning more than 200 diseases and used on five continents. The company serves pharmaceutical, healthcare, and public sector clients, delivering up to 600% ROI and 65% time savings for bioinformaticians. Lifebit is recognized for pioneering federated data solutions that enable collaborative, secure, and scalable biomedical research, trusted by leading global biomedical organizations.

Lifebit is a precision medicine software company specializing in enterprise data platforms for sensitive genomic and biomedical datasets. Their patented federated technology enables secure, in-situ analysis of distributed clinical and multi-omic data without moving it, preserving data privacy and compliance. Key products include the Lifebit Federated Platform, Trusted Data Lakehouse, Trusted Research Environment (TRE), and AI-driven tools like Target ID and NF-Copilot. Lifebit's platform supports large-scale biomedical data research across over 250 million patient datasets globally, spanning more than 200 diseases and used on five continents. The company serves pharmaceutical, healthcare, and public sector clients, delivering up to 600% ROI and 65% time savings for bioinformaticians. Lifebit is recognized for pioneering federated data solutions that enable collaborative, secure, and scalable biomedical research, trusted by leading global biomedical organizations.
What they do: Federated, AI-powered data intelligence platform for secure biomedical and genomics research
Founded: 2017
Founders / leadership: Dr. Maria Chatzou Dunford (CEO), Dr. Pablo Prieto Barja (CTO)
Scale / reach: Platform used across >250M patient datasets and five continents
Recent funding: Series B $60M (Sep 28, 2021); total disclosed funding ~$70.62M
Secure analysis and sharing of sensitive genomic and health data for research and drug discovery.
2017
Biotechnology Research
3000000
Seed round participants included Connect Ventures, Beacon Capital and Tiny VC
60000000
Existing investors Eurazeo, Pentech Ventures and Beacon Capital participated
“Tiger Global Management led the Series B; other investors across rounds include Eurazeo, Pentech Ventures, Beacon Capital, Connect Ventures, Tiny Supercomputer Investment Company and others”
| Company |
|---|